Bifogade filer
Kurs
+9,34%
Kalender
Est. tid* | ||
2025-09-24 | N/A | Årsstämma |
2025-06-03 | 07:00 | Bokslutskommuniké 2025 |
2025-03-03 | - | Kvartalsrapport 2025-Q3 |
2025-01-20 | - | Extra Bolagsstämma 2025 |
2024-12-04 | - | Kvartalsrapport 2025-Q2 |
2024-09-26 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2024-09-25 | - | Årsstämma |
2024-08-29 | - | Kvartalsrapport 2025-Q1 |
2024-05-30 | - | Bokslutskommuniké 2024 |
2024-02-29 | - | Kvartalsrapport 2024-Q3 |
2023-12-04 | - | Kvartalsrapport 2024-Q2 |
2023-10-04 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2023-09-27 | - | Årsstämma |
2023-08-31 | - | Kvartalsrapport 2024-Q1 |
2023-06-08 | - | Bokslutskommuniké 2023 |
2023-03-01 | - | Kvartalsrapport 2023-Q3 |
2022-12-01 | - | Kvartalsrapport 2023-Q2 |
2022-10-03 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2022-09-28 | - | Årsstämma |
2022-08-31 | - | Kvartalsrapport 2023-Q1 |
2022-06-10 | - | Bokslutskommuniké 2022 |
2022-03-02 | - | Kvartalsrapport 2022-Q3 |
2021-12-02 | - | Kvartalsrapport 2022-Q2 |
2021-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2021-09-02 | - | Kvartalsrapport 2022-Q1 |
2021-05-31 | - | Bokslutskommuniké 2021 |
2021-03-03 | - | Kvartalsrapport 2021-Q3 |
2020-12-02 | - | Kvartalsrapport 2021-Q2 |
2020-09-30 | - | Årsstämma |
2020-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2020-08-24 | - | Kvartalsrapport 2021-Q1 |
2020-06-08 | - | Bokslutskommuniké 2020 |
2020-04-20 | - | Extra Bolagsstämma 2020 |
2020-03-02 | - | Kvartalsrapport 2020-Q3 |
2019-12-02 | - | Kvartalsrapport 2020-Q2 |
2019-09-30 | - | Årsstämma |
2019-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2019-09-02 | - | Kvartalsrapport 2020-Q1 |
2019-06-10 | - | Bokslutskommuniké 2019 |
2019-03-04 | - | Kvartalsrapport 2019-Q3 |
2018-12-17 | - | Kvartalsrapport 2019-Q2 |
2018-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2018-09-24 | - | Årsstämma |
2018-09-24 | - | Kvartalsrapport 2019-Q1 |
2018-06-25 | - | Bokslutskommuniké 2018 |
2018-03-26 | - | Kvartalsrapport 2018-Q3 |
2017-12-18 | - | Kvartalsrapport 2018-Q2 |
2017-09-25 | - | Årsstämma |
2017-09-25 | - | Kvartalsrapport 2018-Q1 |
2017-06-30 | - | Bokslutskommuniké 2017 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Mölndal, Sweden, December 23, 2021 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announced today its plans to support the US Department of Veterans Affairs program to offer the OPRA™ Implant System to select Veterans who meet criteria for the implant system.
The Department of Veterans Affairs (VA) administers the largest integrated health care system in the United States, providing care at nearly 1,300 health care facilities to over 9 million military Veterans enrolled in the VA health care program. The VA has developed a process by which Veterans can be evaluated to determine if they are appropriate for this new technology and the VA plans to start screening potential candidates early in 2022.
"We are very excited about these plans and our working relationship in integrating the OPRA[TM] Implant System into the VA system. The VA program builds upon our initial work with the Department of Defense and Walter Reed National Military Medical Center providing the revolutionary OPRA[TM] technology to military members with limb loss," said Tom Dugan, President, Integrum Inc, US.
This information is such that Integrum AB (publ) is required to publish in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the agency by the contact persons set out below on December 23, 2021, at 7:00 pm (CET).
María López, CEO. +46 (0) 70 846 10 69, E-mail: maria.lopez@integrum.se
Dennis Baecklund, CFO. Phone: +46 (0) 72 556 68 69, E-mail: dennis.baecklund@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8 463 8000, Email: certifiedadviser@penser.se